2BBBullish & Bearish
Evommune, Inc. Common Stock (EVMN) trades on NYSE. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 25 out of 100.
Evommune, Inc. Common Stock’s current 2BB score is 25 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 12 | Very Low |
| Momentum | 50 | Stable |
| Financial strength | 48 | Normal |
| Quality | 60 | Strong |
| Risk | 44 | Moderate |
| Headquarters | Palo Alto, California, United States |
| Founded | 2020 |
| Employees | 48 |
| 52-week range | $12.65 – $33.20 |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2027-03-03 | — | -0.922 | — | $0.00 |
| 2026-12-09 | — | -0.8565 | — | $0.00 |